These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 32265224)

  • 21. Targeted inhibition of SCF
    Wang J; Ferrena A; Zhang R; Singh S; Viscarret V; Al-Harden W; Aldahamsheh O; Borjihan H; Singla A; Yaguare S; Tingling J; Zi X; Lo Y; Gorlick R; Schwartz EL; Zhao H; Yang R; Geller DS; Zheng D; Hoang BH
    Oncogene; 2024 Mar; 43(13):962-975. PubMed ID: 38355807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes.
    Offin M; Chan JM; Tenet M; Rizvi HA; Shen R; Riely GJ; Rekhtman N; Daneshbod Y; Quintanal-Villalonga A; Penson A; Hellmann MD; Arcila ME; Ladanyi M; Pe'er D; Kris MG; Rudin CM; Yu HA
    J Thorac Oncol; 2019 Oct; 14(10):1784-1793. PubMed ID: 31228622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).
    Mamillapalli R; Gavrilova N; Mihaylova VT; Tsvetkov LM; Wu H; Zhang H; Sun H
    Curr Biol; 2001 Feb; 11(4):263-7. PubMed ID: 11250155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancer.
    He DH; Chen YF; Zhou YL; Zhang SB; Hong M; Yu X; Wei SF; Fan XZ; Li SY; Wang Q; Lu Y; Liu YQ
    Cancer Sci; 2021 Aug; 112(8):3218-3232. PubMed ID: 34080260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant.
    Ji P; Jiang H; Rekhtman K; Bloom J; Ichetovkin M; Pagano M; Zhu L
    Mol Cell; 2004 Oct; 16(1):47-58. PubMed ID: 15469821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trp53 and Rb1 regulate autophagy and ligand-dependent Hedgehog signaling.
    Cochrane CR; Vaghjiani V; Szczepny A; Jayasekara WSN; Gonzalez-Rajal A; Kikuchi K; McCaughan GW; Burgess A; Gough DJ; Watkins DN; Cain JE
    J Clin Invest; 2020 Aug; 130(8):4006-4018. PubMed ID: 32568216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing structure-activity relationships from an HTS hit for inhibition of the Cks1-Skp2 protein-protein interaction.
    Singh R; Sran A; Carroll DC; Huang J; Tsvetkov L; Zhou X; Sheung J; McLaughlin J; Issakani SD; Payan DG; Shaw SJ
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5199-202. PubMed ID: 26463131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer.
    Bhateja P; Chiu M; Wildey G; Lipka MB; Fu P; Yang MCL; Ardeshir-Larijani F; Sharma N; Dowlati A
    Cancer Med; 2019 Apr; 8(4):1459-1466. PubMed ID: 30773851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.
    Fiorentino FP; Tokgün E; Solé-Sánchez S; Giampaolo S; Tokgün O; Jauset T; Kohno T; Perucho M; Soucek L; Yokota J
    Oncotarget; 2016 May; 7(21):31014-28. PubMed ID: 27105536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of ubiquitin ligase SCF(Skp2) by Cks1: insights from hydrogen exchange mass spectrometry.
    Yao ZP; Zhou M; Kelly SE; Seeliger MA; Robinson CV; Itzhaki LS
    J Mol Biol; 2006 Oct; 363(3):673-86. PubMed ID: 16979657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of Novel [1,2,4]Triazolo[1,5-
    Hu K; Luo Y; Miao P; Zhao L; Zhao B; Shi XJ; Liu HM
    J Med Chem; 2024 Sep; 67(18):16435-16454. PubMed ID: 39285177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors.
    Kohlmeyer JL; Kaemmer CA; Pulliam C; Maharjan CK; Samayoa AM; Major HJ; Cornick KE; Knepper-Adrian V; Khanna R; Sieren JC; Leidinger MR; Meyerholz DK; Zamba KD; Weimer JM; Dodd RD; Darbro BW; Tanas MR; Quelle DE
    Clin Cancer Res; 2020 Jun; 26(12):2997-3011. PubMed ID: 32086342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
    Appleman LJ; Chernova I; Li L; Boussiotis VA
    Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics and chemical library screens reveal a novel SCF
    Malek E; Abdel-Malek MA; Jagannathan S; Vad N; Karns R; Jegga AG; Broyl A; van Duin M; Sonneveld P; Cottini F; Anderson KC; Driscoll JJ
    Leukemia; 2017 Mar; 31(3):645-653. PubMed ID: 27677741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1.
    Hu K; Li XJ; Asmamaw MD; Shi XJ; Liu HM
    Sci Rep; 2021 Oct; 11(1):21105. PubMed ID: 34702937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of Cks1 and Skp2 with TNFα/NF-κB signaling in chronic progressive nephropathy.
    Suzuki S; Fukasawa H; Misaki T; Togawa A; Ohashi N; Kitagawa K; Kotake Y; Niida H; Hishida A; Yamamoto T; Kitagawa M
    Genes Cells; 2011 Nov; 16(11):1110-20. PubMed ID: 22017545
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Jia D; Augert A; Kim DW; Eastwood E; Wu N; Ibrahim AH; Kim KB; Dunn CT; Pillai SPS; Gazdar AF; Bolouri H; Park KS; MacPherson D
    Cancer Discov; 2018 Nov; 8(11):1422-1437. PubMed ID: 30181244
    [No Abstract]   [Full Text] [Related]  

  • 38. SKP2 Activation by Thyroid Hormone Receptor β2 Bypasses Rb-Dependent Proliferation in Rb-Deficient Cells.
    Xu XL; Li Z; Liu A; Fan X; Hu DN; Qi DL; Chitty DW; Jia R; Qui J; Wang JQ; Sharaf J; Zou J; Weiss R; Huang H; Joseph WJ; Ng L; Rosen R; Shen B; Reid MW; Forrest D; Abramson DH; Singer S; Cobrinik D; Jhanwar SC
    Cancer Res; 2017 Dec; 77(24):6838-6850. PubMed ID: 28972075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
    Uehara N; Yoshizawa K; Tsubura A
    Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryo-EM structure of SKP1-SKP2-CKS1 in complex with CDK2-cyclin A-p27KIP1.
    Rowland RJ; Heath R; Maskell D; Thompson RF; Ranson NA; Blaza JN; Endicott JA; Noble MEM; Salamina M
    Sci Rep; 2023 Jul; 13(1):10718. PubMed ID: 37400515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.